Broadly neutralizing antibodies

by cailynn on Mar 6th, 2025 07:47 AM

Broadly neutralizing antibodies (bNAbs) are a promising solution in the fight against influenza virus due to their ability to target multiple strains. These antibodies bind to conserved regions of the virus, preventing infection and reducing the need for strain-specific vaccines. Research on bNAbs is advancing rapidly, offering hope for more effective and universal influenza treatments. Their development could significantly improve global health outcomes by providing long-lasting protection against seasonal and pandemic flu strains.